eprintid: 10156760
rev_number: 13
eprint_status: archive
userid: 699
dir: disk0/10/15/67/60
datestamp: 2022-10-05 14:04:12
lastmod: 2023-09-25 10:30:00
status_changed: 2022-10-05 14:04:12
type: article
metadata_visibility: show
sword_depositor: 699
creators_name: Rua, Joana
creators_name: Dall'Era, Maria
creators_name: Isenberg, David
title: The use of combination monoclonal antibody therapies in lupus—where are we now?
ispublished: pub
divisions: C10
divisions: D17
divisions: B02
divisions: UCL
note: This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions.
date: 2023-05
date_type: published
publisher: Oxford University Press (OUP)
official_url: https://doi.org/10.1093/rheumatology/keac482
oa_status: green
full_text_type: other
language: eng
primo: open
primo_central: open_green
verified: verified_manual
elements_id: 1978510
doi: 10.1093/rheumatology/keac482
medium: Print-Electronic
pii: 6700640
lyricists_name: Isenberg, David
lyricists_id: DAISE40
actors_name: Isenberg, David
actors_name: Geary, Esther
actors_id: DAISE40
actors_id: ECGEA88
actors_role: owner
actors_role: impersonator
full_text_status: public
publication: Rheumatology
volume: 62
number: 5
pagerange: 1724-1729
event_location: England
citation:        Rua, Joana;    Dall'Era, Maria;    Isenberg, David;      (2023)    The use of combination monoclonal antibody therapies in lupus—where are we now?                   Rheumatology , 62  (5)   pp. 1724-1729.    10.1093/rheumatology/keac482 <https://doi.org/10.1093/rheumatology%2Fkeac482>.       Green open access   
 
document_url: https://discovery.ucl.ac.uk/id/eprint/10156760/1/Isenberg_The%20use%20of%20combination%20monoclonal%20antibody%20therapies%20in%20lupus%20-%20where%20are%20we%20now%20CLEAN%20COPY%2011.08.2022.pdf